An array of respiratory professionals will gather on 2nd and 3rd April at the Marriott Regents Park Hotel in London, to identify cutting-edge developments in COPD.
"The strength of this conference is that it will bring together senior leaders from across the key disciplines that work together to make a difference..."
Case study driven presentations from leading pharmaceutical and regulatory KOLS including University College London, Novartis, Astra Zeneca, Teva, National Heart & Lung Institute, British Lung Foundation, MHRA, key U-BIOPRED committee members and MedImmune
Topics covered will include a review of mAbs as a treatment for severe asthma and COPD, drug development, combination therapies with insights into LABA/LAMA, biomarker development for respiratory drug assessment, market access and patient stratification.
This is just a snapshot of what will be covered. For further details on the conference agenda, speakers and for short interviews visit http://www.smi-
The Asthma & COPD Team 2014
2ND-3RD APRIL 2014
Marriott Regents Park Hotel, London UK
About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-
We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.
More information can be found at http://www.smi-online.co.uk